Note 2 - Restatement of Previously Issued Financial Statements (Tables)

12 Months Ended

Mar. 31, 2018

Notes Tables

Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]

	Consolidated Statements of Earnings (Loss)
	Year Ended
	March 31, 2017 (Audited)						March 31, 2016 (Audited)
	As				As		As				As
	Reported		Correction		Restated		Reported		Correction		Restated
Net Sales	$	1,245,681	$	16,517	$	1,262,198	$	1,275,360	$	4,207	$	1,279,567
Cost of Products Sold		1,139,298		10,896		1,150,194		1,127,965		1,025		1,128,990
Gross Profit		106,383		5,621		112,004		147,395		3,182		150,577
Operating Income/(Loss)		29,121		5,621		34,742		88,549		3,182		91,731
Earnings/(Loss) before income taxes		20,027		5,621		25,648		80,457		3,182		83,639
Income tax (benefit) expense		7,414		2,339		9,753		25,999		1,241		27,240
Net Earnings		12,613		3,282		15,895		54,458		1,941		56,399
Earnings Per Common Share-Basic	$	1.27	$	0.34	$	1.61	$	5.46	$	0.20	$	5.65
Earnings Per Common Share-Diluted	$	1.27	$	0.33	$	1.60	$	5.42	$	0.20	$	5.61

	Three Months Ended
	December 30, 2017 (Unaudited)								September 30, 2017 (Unaudited)
	As						As		As						As
	Reported			Correction			Restated		Reported			Correction			Restated
Net Sales	$	392,714		$	(5,025	)	$	387,689	$	376,308		$	(37,838	)	$	338,470
Cost of Products Sold		361,013			(3,825	)		357,188		355,904			(34,845	)		321,059
Gross Profit		31,701			(1,200	)		30,501		20,404			(2,993	)		17,411
Operating Income/(Loss)		11,471			(1,200	)		10,271		1,584			(2,993	)		(1,409	)
Earnings/(Loss) before income taxes		7,459			(1,200	)		6,259		(1,849	)		(2,993	)		(4,842	)
Income tax (benefit) expense		(268	)		2,150			1,882		(737	)		(1,147	)		(1,884	)
Net Earnings (Loss)		7,727			(3,350	)		4,377		(1,112	)		(1,846	)		(2,958	)
Earnings Per Common Share-Basic	$	0.79		$	(0.34	)	$	0.45	$	(0.11	)	$	(0.19	)	$	(0.30	)
Earnings Per Common Share-Diluted	$	0.78		$	(0.34	)	$	0.44	$	(0.11	)	$	(0.19	)	$	(0.30	)

	Three Months Ended
	July 1, 2017 (Unaudited)									March 31, 2017 (Unaudited)
	As						As			As					As
	Reported			Correction			Restated			Reported			Correction		Restated
Net Sales	$	280,187		$	8,740		$	288,927		$	266,115		$	14,575	$	280,690
Cost of Products Sold		264,427			8,965			273,392			247,394			12,198		259,592
Gross Profit		15,760			(225	)		15,535			18,721			2,377		21,098
Operating Income/(Loss)		838			(225	)		613			2,432			2,377		4,809
Earnings/(Loss) before income taxes		(2,358	)		(225	)		(2,583	)		(453	)		2,377		1,924
Income tax (benefit) expense		(1,519	)		(84	)		(1,603	)		1,197			407		1,604
Net Earnings (Loss)		(839	)		(141	)		(980	)		(1,650	)		1,970		320
Earnings Per Common Share-Basic	$	(0.09	)	$	(0.01	)	$	(0.10	)	$	(0.17	)	$	0.20	$	0.03
Earnings Per Common Share-Diluted	$	(0.09	)	$	(0.01	)	$	(0.10	)	$	(0.17	)	$	0.20	$	0.03

	Three Months Ended
	December 31, 2016 (Unaudited)							October 1, 2016 (Unaudited)
	As					As		As					As
	Reported		Correction			Restated		Reported		Correction			Restated
Net Sales	$	369,705	$	(12,938	)	$	356,767	$	357,247	$	(4,641	)	$	352,606
Cost of Products Sold		332,230		(13,389	)		318,841		327,035		(5,454	)		321,581
Gross Profit		37,475		451			37,926		30,212		813			31,025
Operating Income/(Loss)		13,890		451			14,341		11,202		813			12,015
Earnings/(Loss) before income taxes		11,809		451			12,260		8,781		813			9,594
Income tax (benefit) expense		3,628		843			4,471		2,637		136			2,773
Net Earnings (Loss)		8,181		(392	)		7,789		6,144		677			6,821
Earnings Per Common Share-Basic	$	0.83	$	(0.05	)	$	0.78	$	0.62	$	0.07		$	0.69
Earnings Per Common Share-Diluted	$	0.82	$	(0.05	)	$	0.77	$	0.62	$	0.07		$	0.69

	Three Months Ended
	July 2, 2016 (Unaudited)
	As					As
	Reported			Correction		Restated
Net Sales	$	252,614		$	19,521	$	272,135
Cost of Products Sold		232,639			17,541		250,180
Gross Profit		19,975			1,980		21,955
Operating Income/(Loss)		1,597			1,980		3,577
Earnings/(Loss) before income taxes		(110	)		1,980		1,870
Income tax (benefit) expense		(48	)		953		905
Net Earnings (Loss)		(62	)		1,027		965
Earnings Per Common Share-Basic	$	(0.01	)	$	0.10	$	0.09
Earnings Per Common Share-Diluted	$	(0.01	)	$	0.10	$	0.09

	Consolidated Balance Sheets
	As of December 30, 2017 (Unaudited)							As of September 30, 2017 (Unaudited)
	As					As		As					As
	Reported		Correction			Restated		Reported		Correction			Restated
Assets
Inventory	$	710,118	$	60,584		$	770,702	$	802,387	$	56,759		$	859,146
Total Current Assets		794,510		60,584			855,094		932,609		56,759			989,368
Total Assets		1,072,003		62,234			1,134,237		1,209,968		61,976			1,271,944
Liabilities and Stockholders' Equity
Deferred Revenue	$	545	$	79,606		$	80,151	$	542	$	74,608		$	75,150
Total Current Liabilities		162,423		79,576			241,999		322,982		74,551			397,533
Total Liabilities		635,204		76,594			711,798		780,214		72,986			853,200
Stockholders' Equity		436,799		(14,360	)		422,439		429,754		(11,010	)		418,744
Total Liabilities and Stockholders' Equity		1,072,003		62,234			1,134,237		1,209,968		61,976			1,271,944

	As of July 1, 2017 (Unaudited)							As of March 31, 2017 (Audited)
	As					As		As					As
	Reported		Correction			Restated		Reported		Correction			Restated
Assets
Inventory	$	633,505	$	21,914		$	655,419	$	598,056	$	30,879		$	628,935
Total Current Assets		731,857		21,914			753,771		688,270		30,879			719,149
Total Assets		1,006,943		25,038			1,031,981		946,019		32,249			978,268
Liabilities and Stockholders' Equity
Deferred Revenue	$	472	$	36,865		$	37,337	$	545	$	45,555		$	46,100
Total Current Liabilities		164,200		36,713			200,913		132,277		45,487			177,764
Total Liabilities		573,449		34,202			607,651		511,758		41,306			553,064
Stockholders' Equity		433,494		(9,164	)		424,330		434,261		(9,057	)		425,204
Total Liabilities and Stockholders' Equity		1,006,943		25,038			1,031,981		946,019		32,249			978,268

	As of December 31, 2016 (Unaudited)							As of October 1, 2016 (Unaudited)
	As					As		As					As
	Reported		Correction			Restated		Reported		Correction			Restated
Assets
Inventory	$	656,368	$	43,077		$	699,445	$	771,996	$	29,688		$	801,684
Total Current Assets		750,156		43,077			793,233		905,029		29,688			934,717
Total Assets		1,004,711		49,035			1,053,746		1,148,714		36,489			1,185,203
Liabilities and Stockholders' Equity
Deferred Revenue	$	473	$	60,080		$	60,553	$	550	$	47,166		$	47,716
Total Current Liabilities		178,732		60,039			238,771		312,466		47,112			359,578
Total Liabilities		587,097		60,039			647,136		738,474		47,112			785,586
Stockholders' Equity		417,614		(11,004	)		406,610		410,240		(10,623	)		399,617
Total Liabilities and Stockholders' Equity		1,004,711		49,035			1,053,746		1,148,714		36,489			1,185,203

	As of July 2, 2016 (Unaudited)							As of March 31, 2016 (Audited)
	As					As		As					As
	Reported		Correction			Restated		Reported		Correction			Restated
Assets
Inventory	$	586,829	$	24,234		$	611,063	$	567,707	$	41,774		$	609,481
Total Current Assets		693,649		24,234			717,883		673,887		41,774			715,661
Total Assets		919,981		31,171			951,152		895,327		49,664			944,991
Liabilities and Stockholders' Equity
Deferred Revenue	$	492	$	42,576		$	43,068	$	550	$	62,034		$	62,584
Total Current Liabilities		179,579		42,471			222,050		399,458		62,003			461,461
Total Liabilities		515,339		42,471			557,810		490,153		62,003			552,156
Stockholders' Equity		404,642		(11,300	)		393,342		405,174		(12,339	)		392,835
Total Liabilities and Stockholders' Equity		919,981		31,171			951,152		895,327		49,664			944,991